Literature DB >> 11543990

beta-carboline binding to imidazoline receptors.

S M Husbands1, R A Glennon, S Gorgerat, R Gough, R Tyacke, J Crosby, D J Nutt, J W Lewis, A L Hudson.   

Abstract

A series of beta-carbolines were prepared and their affinities for imidazoline (I(1) and I(2)) sites evaluated. Selected compounds were also examined at alpha(2)-adrenoceptors. Some of the beta-carbolines were found to bind with high affinity to I(2)-sites and this affinity was dependent on both the planarity of the molecule and the presence of the aryl ring substituents. Good I(1)-affinity was observed with two of the compounds but none of the tested compounds bound to alpha(2)-adrenoceptors. The hallucinogenic properties of beta-carbolines have been linked to activity at 5-HT receptors, in particular 5-HT(2), however, it is apparent from this study that many of these compounds display substantially higher affinity for the imidazoline sites. This finding, and those showing modulation of some behavioural effects of morphine by I(2)-ligands, suggests that imidazoline sites may be interesting new targets in drug abuse research.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11543990     DOI: 10.1016/s0376-8716(01)00123-5

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  18 in total

Review 1.  Imidazoline binding sites on receptors and enzymes: emerging targets for novel antidepressant drugs?

Authors:  Andrew Holt
Journal:  J Psychiatry Neurosci       Date:  2003-11       Impact factor: 6.186

2.  Harmine, a natural beta-carboline alkaloid, upregulates astroglial glutamate transporter expression.

Authors:  Yun Li; Rita Sattler; Eun Ju Yang; Alice Nunes; Yoko Ayukawa; Sadia Akhtar; Grace Ji; Ping-Wu Zhang; Jeffrey D Rothstein
Journal:  Neuropharmacology       Date:  2010-10-27       Impact factor: 5.250

3.  Differential effects of non-nicotine tobacco constituent compounds on nicotine self-administration in rats.

Authors:  Brandon J Hall; Corinne Wells; Cheyenne Allenby; Mung Yan Lin; Ian Hao; Lindsey Marshall; Jed E Rose; Edward D Levin
Journal:  Pharmacol Biochem Behav       Date:  2014-02-21       Impact factor: 3.533

4.  Chronic administration of harmine elicits antidepressant-like effects and increases BDNF levels in rat hippocampus.

Authors:  Jucélia J Fortunato; Gislaine Z Réus; Tamires R Kirsch; Roberto B Stringari; Gabriel R Fries; Flávio Kapczinski; Jaime E Hallak; Antônio W Zuardi; José A Crippa; João Quevedo
Journal:  J Neural Transm (Vienna)       Date:  2010-08-05       Impact factor: 3.575

5.  Analysing the effect of I1 imidazoline receptor ligands on DSS-induced acute colitis in mice.

Authors:  Ágnes Fehér; Viktória E Tóth; Mahmoud Al-Khrasani; Mihály Balogh; Bernadette Lázár; Zsuzsanna Helyes; Klára Gyires; Zoltán S Zádori
Journal:  Inflammopharmacology       Date:  2016-11-21       Impact factor: 4.473

6.  Harmane inhibits serotonergic dorsal raphe neurons in the rat.

Authors:  Khalid Touiki; Pascal Rat; Robert Molimard; Abderrahman Chait; Renaud de Beaurepaire
Journal:  Psychopharmacology (Berl)       Date:  2005-10-19       Impact factor: 4.530

7.  In vivo comparison of harmine efficacy against psychostimulants: preferential inhibition of the cocaine response through a glutamatergic mechanism.

Authors:  Suzan Owaisat; Robert B Raffa; Scott M Rawls
Journal:  Neurosci Lett       Date:  2012-08-03       Impact factor: 3.046

Review 8.  Indolealkylamines: biotransformations and potential drug-drug interactions.

Authors:  Ai-Ming Yu
Journal:  AAPS J       Date:  2008-05-03       Impact factor: 4.009

9.  β-Carbolines found in cigarette smoke elevate intracranial self-stimulation thresholds in rats.

Authors:  Andrew C Harris; Peter Muelken; Mark G LeSage
Journal:  Pharmacol Biochem Behav       Date:  2020-09-11       Impact factor: 3.533

10.  Harmine, a Novel DNA Methyltransferase 1 Inhibitor in the Leukemia Cell Line.

Authors:  Arezoo Oodi; Hamed Norouzi; Naser Amirizadeh; Mahin Nikougoftar; Zahra Vafaie
Journal:  Indian J Hematol Blood Transfus       Date:  2017-01-17       Impact factor: 0.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.